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The level of coverage of ACTs was found to be very low in the study population. Six years since the 
adoption of this policy in Nigeria, our findings shows that a change policy alone is not sufficient. 
Steps needs to taken to ensure that the policy is implemented and that effective medications for 
malaria treatment reach the people who need it.  The gap in knowledge on the current treatment policy 




























Malaria remains a major cause of morbidity and mortality, especially among children and 
pregnant women in Africa (Snow et al. 2005). In Nigeria, at least 300,000 children die of 
malaria annually. Malaria is responsible for 60% of outpatients' visits, 30% of childhood 
mortality, 25% of infant mortality and 11% of maternal deaths in Nigeria (Federal Ministry 
2005). According to the World Health Organization (WHO), Nigeria accounts for a quarter of 
all malaria cases in the African Region and that, there is no evidence of any systematic 
decline in the malaria burden (WHO 2008). This is despite a progressive increase in the 
amount of funding that has gone into the control of malaria in the country. It has been 
estimated that between 3-11% of annual household income in Nigeria could be lost due to 
malaria (Leighton& Foster 1993). 
Early diagnosis and prompt treatment of malaria with effective medications reduces 
morbidity and prevents death from the disease. Various studies have shown that the 
affordable and widely available antimalaria – chloroquine (CQ) – which was the major first-
line drug has lost its efficacy due to the emergence of CQ-resistant strains of Plasmodium 
falciparum (WHO 2008). For example In Nigeria, a nationwide study showed that CQ and 
sulphadoxine-pyrimethamine (SP) are no longer effective treatment options for malaria 
(Federal Ministry of Health 2005a). Artemisinin based combination therapies (ACTs)1 have 
been shown to be highly effective at treating P. falciparum in most places where they have 
been studied (Sinclair et al. 2009). The WHO in April 2001 recommended the use of ACTs in 
countries where Plasmodium falciparum malaria is resistant to CQ, SP and amodiaquine 
(WHO 2006a).  
In 2004, the Federal Government of Nigeria in compliance with the WHO recommendation 
banned the use of CQ and SP as first-line drugs in the treatment of malaria. ACTs became the 
recommended first-line drugs for the treatment of uncomplicated malaria in Nigeria (Federal 
Ministry of Health 2005b). The policy change from CQ and SP to ACT in Nigeria is expected 
to change malaria treatment and drug consumption patterns from the use of cheaper but 
ineffective drugs to the use of ACTs. More than 6 years after the change in treatment policy, 
it is not certain if the policy is being adhered to and the proportion of people that use the 
recommended ACT in Nigeria is not known (WHO 2009).  
                                                 
1 An ACT is a combination of Artemisinin (or one of its derivatives) with another 














Despite ACTs being WHO preferred treatment for malaria since 2001, few people in 
developing countries can afford them (AMFm 2008). However, the global community is 
considering the setting up of a global subsidy mechanism in order to make ACTs accessible 
and affordable. With funding from the Global Fund, the U.S. President’s Malaria Initiative, 
the World Bank, and others, many of these countries have made substantial progress in 
delivering ACTs to patients through public health systems (UNICEF 2009).  
 
2. Research Problem  
 
The Roll Back Malaria Partnership (RBM) has set the target for 2010 of “80% of malaria 
patients are diagnosed and treated with effective anti-malarial medicines e.g. ACTs within 
one day of the onset of illness” (RBM 2005). Because prompt and effective treatment was 
proposed as a malaria control strategy by the WHO, various interventions aimed at the 
various factors that influence prompt and effective treatment have been developed and 
implemented. These include interventions aimed at improving the prescription and dispensing 
practices of providers and interventions aimed at the purchasing and adherence practices of 
anti-malarial users and their caretakers (Smith et al. 2009).  
Even though many countries have adopted ACTs as the medication for the treatment of 
uncomplicated malaria, only a fraction, probably < 10% of malaria patients, are able to access 
these medicines, especially in high burden countries in Africa (Bosman & Mendis, 2007). 
The mean proportion of children under five years of age with a fever that were treated with 
an anti-malarial drug in sub-Saharan Africa between 2006 and 2007 was 38%, although this 
varied across countries from 10% to 63%. While anti-malarial treatment in children with 
fever is moderately high across Africa, many febrile children are still treated at home and 
with less effective medicines (UNICEF, 2009). Only about 3% of these children were given 
an ACT (WHO, 2008). Of the approximately 550 million anti-malarial treatments 
administered per year globally, only 110 million or 20% are ACTs – and these are provided 
almost entirely by the public sector. Currently ACTs make up approximately 5% of total anti-
malarial treatments provided by the private sector where 60-80% of patients purchase drugs 
(AMFm, 2008). 
In most countries, ACTs are currently the most expensive drugs for treating malaria.  In 
Nigeria for instance, it averages 504 Naira (US$ 4) per course of treatment, up to 10 times 













in the private sector are accessing ACTs, but are instead continuing to purchase suboptimal 
therapies such as SP and CQ or antipyretics (Laxminarayan et al. 2006). 
Most people do not obtain appropriate treatment for malaria, and depend on informal private 
providers for anti-malarial drugs, mainly through patent medicine vendors (PMVs). These 
medicine sellers are a widely used source of drugs for fever in sub-Saharan Africa (Goodman 
et al. 2007). In this era of ACT, there is concern that medicine sellers may continue to sell 
artemisinin monotherapies, potentially jeopardizing ACT efficacy in the long-term (Kachur et 
al. 2006). The use of Artemisinin monotherapies could lead to the development of parasite 
resistance to Artemisinin.  
A lot of effort has gone into determining which anti-malarials are efficacious, however far 
less effort has gone into determining how to deliver them effectively. A drug which is 90% 
efficacious but delivered to only 20% of those who need it has limited effectiveness (Whitty 
et al. 2008). 
 
3. Aim and Objectives:  
3.1. Aim: The aim of this study is to explore how demographic and socioeconomic factors 
influence malaria treatment seeking behaviour and anti-malarial drug use patterns of 




 To determine where target population seek treatment for malaria. 
 To determine the proportion of target populations who used a formal malaria diagnostic 
test to confirm symptoms of malaria. 
 To assess the level of awareness of the ACTs for malaria treatment. 
 To determine the proportion of the target population with fever in the last 4 weeks who 
received effective malaria treatment (ACT). 




















4. Justification of study  
Health care seeking is a central issue in all kinds of morbidity including malaria. The duration 
of symptoms increases the probability of severe morbidity and harmful consequences. Also, 
the quality and type of drug used would determine treatment outcomes. Initiatives such as the 
RBM have emphasized the importance of social science inputs to malaria research and 
control (Williams & Jones 2004). Also, exploring socio-cultural factors which influence 
antimalarial drug use has been recognized as a priority (Gardella et al. 2008). Information on 
treatment seeking behaviour and drug use patterns has important policy implications in health 
systems development. Strategic policy formation in all health care systems should be based 
on information relating to health promotion, seeking and utilization behaviour and the factors 
determining these behaviours (Shaikh & Hatcher, 2005). Such information is pertinent to help 
the government in the promotion of equitable access to quality health services and access to 
effective medications. 
Many studies have been carried out on treatment seeking patterns for malaria particularly 
among children under 5 years of age in sub-Saharan Africa; however, most of these studies 
were done before the adoption of ACTs as first-line drugs for malaria (Tanner & Vlassoff, 
1998). Earlier studies conducted in Nigeria did not assess household awareness about ACTs 
and did not provide information on the proportion of people that currently use ACTs for 
treating malaria (Uzochukwu & Onwujekwe, 2004, Okeke & Okafor 2008). Other studies in 
Nigeria assessed drug prescription and consumption patterns at formal health facilities 
(Meremikwu et al., 2007, Oreagba et al. 2008). However, it is well known that most 
treatment of malaria occurs at household level either by self treatment or by purchasing of 
drugs from PMVs (Oladepo et al. 2007). Anti-malarial drug consumption patterns at hospital 
and clinics did not capture the drug use behaviour of the millions of people in Nigeria who do 
not access treatment from formal health facilities. Therefore, currently there is limited 
information on treatment seeking behaviour for malaria and antimalarial drug use patterns 
since the ACTs policy.  
About six years down the line, after the adoption of the ACT policy, household awareness of 
the policy, malaria treatment seeking behaviour and anti-malarial drug consumption patterns 
need to be explored. The findings of this study would add to the current literature on the 
malaria treatment seeking behaviour and drug use patterns following the national policy 
change to ACTs for malaria treatment and access to effective malaria medicines. It will also 
provide relevant information on variables that have to be considered when planning malaria 













5. Literature Review 
Human health seeking behaviour, which is the action people take when dealing with an 
illness, is influenced by a multiple of factors apart from knowledge and awareness (Jain et al. 
2006). Some of these factors are predisposing characteristics such as age, gender, occupation, 
education and other enabling factors such as proximity to the health facility, health insurance, 
income and existence of social networks (Law et al. 2005). Several theoretical models have 
been used to explain the determinants of health seeking behaviour. One of these is the model 
developed by Andersen which includes 3 groups of factors, namely; predisposing factors, 
enabling factors and health services system (Andersen 1995). Multiple barriers to accessing 
effective treatment for malaria have been identified. These barriers include: perceived quality 
of care, lack of knowledge, distance from health services, transport costs, treatment costs, and 
opportunity costs (Whitty et al. 2008, Noor et al. 2003). 
 
5.1 Treatment seeking Behaviour 
Early diagnosis and prompt treatment with effective medications has been a cornerstone of 
malaria control (Snow et al. 2005). The use of ineffective drugs in Sub Saharan Africa, in 
recent years has led to treatment failures and elevated rates of mortality, particularly among 
young children (Björkman 2002). Previous studies indicate that most people do not use 
laboratory services for the diagnosis of malaria. Self diagnosis and treatment was noted to be 
rampant in malaria endemic countries (McCombie 2002). Foster estimated that more than 
half of the world’s anti-malarials are consumed outside the public health sector (Foster 1995). 
A survey of 21 African countries revealed that of those who treated febrile illness with anti-
malarials, 46% obtained treatment at a health facility, 44% at home and 10% at both home 
and health facility (UNICEF & WHO 2003). A household survey in central Ethiopia revealed 
that 33% of people with self-diagnosed malaria sought treatment from community based 
health facility workers, 23% attended public health facility and 17% sought help from private 
clinic (Deressa et al. 2007). In a similar study in Sudan, it was found that people usually start 
care at home, and then shift to health workers if there was no response (Malik et al. 2006). 
The findings were similar in Guatemala, Ethiopia and Kenya, where more than 60% of the 
individuals self treated usually with anti-malarials and did not seek medical attention 
(Ruebush et al. 1992, Snow et al. 1992, Yeneneh et al. 1993). According to studies conducted 
in Ghana, Mali, Nigeria and Zambia, as many as 90% of children with fever are treated at 













Home treatment is usually by purchasing medicines from medicines stores (PMV) or by 
using locally prepared concoction. Several studies in Nigeria have shown that PMVs are the 
most common source of malaria treatment for many households (Goodman et al. 2007, 
Salako et al. 2001). Evidence from 2 states in Nigeria shows that for both children and adults, 
about 75% of fever treatment takes place in the private sector. Within the private sector, 
about 40% of treatment seeking is from patent medicine dealers. A study on the role of PMV 
in three regions in Nigeria showed that  PMVs still recommended and provided drugs whose 
efficacy is highly questionable: 92% of shops had SP in stock, 72% had CQ (both not 
recommended), whereas only 9% had ACTs (Oladepo et al. 2007). The PMVs have been 
observed to behave primarily as commercial salesmen, since around 75% simply sell what a 
customer requests, and on other rare occasions, fills a prescription (Brieger et al. 2004). There 
are concerns that the patent medicine vendors have little knowledge about new guidelines for 
malaria treatment and they still recommend that people use ineffective anti-malarials. There 
are also of concern about the quality of the drugs that are supplied by the PMV (Oladepo et 
al. 2007).  
 
  5.2. Determinants of Choice of Treatment 
 
Various factors including the availability of health facilities, user fees, satisfaction with 
services, difficulty to reach the facilities and believe in traditional medicine have been found 
to influence the choice of treatment (Malik et al. 2006). In Nigeria, it has been shown that 
poorer people are more likely to resort to self diagnosis and also rely on a family member to 
diagnose their malaria. Also the poorer the respondents, the more likely they are to  use 
traditional healers, patent medicine dealers and community health workers for the treatment 
of malaria while the rich households are more likely to use the services of private clinics that 
offer apparently better quality of services (Uzochukwu & Onwujekwe 2004). 
5.3 Access to ACTs for malaria treatment 
 
Access can be viewed as a multi dimensional concept. The three common dimensions of 
access include availability (sometimes referred to as physical or spatial access), affordability 
(sometimes referred to as financial access) and acceptability (sometimes referred to as 
cultural access) (McIntyre & Mooney 2007). Accessibility to effective treatment plays a 
significant part in health seeking behaviour. Differences in access between individuals would 













access to treatment with effective anti-malarial drugs is essential to the control and 
elimination of malaria, and to reducing child and adult mortality (Hopkins et al. 2009). For 
example, the widespread use of ACTs in South Africa has reduced the burden of malaria 
significantly (Muheki et al. 2004).   
Even though ACTs are currently a major tool to combat malaria, access to ACTs is still 
inadequate in many countries (WHO 2008). Various forms of ACT are 5–10-fold more costly 
compared with the previously recommended treatments, CQ or SP (Saulo et al. 2008). Efforts 
have been made to improve the availability of these medications and to encourage their 
correct use (Bate et al. 2008). The National Malaria Control Programme (NMCP) programme 
delivered 4.5 million courses of ACT in 2006 and 9 million in 2007, far below total 
requirements (Federal Ministry of Health 2005c). The cost of artemisinin derivatives is also a 
limiting factor for access and optimal use of ACT. According to the WHO, none of the 
populations of 18 African countries surveyed in 2006 and 2007 had adequate access to anti-
malarial drugs (WHO 2008). Access to treatment was not up to the 80% target in any of the 
countries, with the average across the 18 countries being 38%. The overall proportion of 
children with fever receiving anti-malarial drugs for their fever was 31 % and the proportion 
of febrile children receiving anti-malarial drugs within 48 hours was 23.3%. In Nigeria only 
about 34% of children under five with malaria receive any anti-malarial, compared to 58% in 
Cameroon, Zambia and Tanzania (WHO 2008). Thus, despite the fact that ACTs are effective 
in the treatment of malaria, the cost of these drugs can be an obstacle to accessing these 
medications especially for the poor who are mostly affected by the disease.  
6. Methodology 
6.1. Study Area 
Nigeria is located in West Africa and shares land borders with the Republic of Benin in the 
west, Chad and Cameroon in the east, and Niger in the north. Its coast lies on the Gulf of 
Guinea, a part of the Atlantic Ocean, in the south. The three largest and most influential 
ethnic groups in Nigeria are the Hausa, Igbo and Yoruba. The study will be carried out in 
Mushin LGA, Lagos state, which is one of the 36 states of the Federal Republic of Nigeria.  
In land mass, Lagos is the smallest state in Nigeria, with an area of 356,861 hectares of which 
75,755 hectares are wetlands, yet it has the highest population, which is over five per cent of 
the national estimate (Lagosstateonline 2010). According to the results of the 2006 census, 
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The field workers will visit each of the selected households and the household head/care 
giver will be interviewed. In the event that there is no one in the house/home visited the 
interviewer will repeat the visit. If there are more than one household in a building, one 
household will be selected randomly. 
 
6.6. The Survey Instrument 
 
Pre-tested structured questionnaires will be used to collect information from household 
primary care givers or household head on their socio-economic and demographic status and 
use of malaria diagnosis and treatment services for any member of the household who had 
fever/malaria in the last 4 weeks preceding the survey. No household head/care giver will be 
excluded on the basis of age or sex. A written consent will be obtained from the household 
head or his/her representative before administering the household questionnaire. In case the 
household head is illiterate, verbal consent will be obtained. All malaria/fever cases 
(involving children and adults) identified in each of the selected households within 4 weeks 
preceding the date of interview will be considered in the surv y. Information will be collected 
on the type of treatment source and anti-malarial medication that was used. The questionnaire 
will also assess their level of awareness about ACTs. In cases where the respondents cannot 
remember the medication used, pictures/packing as well as tablets of the various anti-malarial 
medications available in the study setting will be used to help the respondents identify the 
medication that was used. The questionnaires will be translated into Yoruba, the indigenous 
language in Lagos. The average duration of each interview will be determined from the pilot 
study. 
 
6.7. Training for Data Collection 	
 
Three data collector with a Health Science University degree will be recruited and trained by 
the Principal Investigator (PI). They will be trained for 2 days- a day before and another day 
after the pilot study. Data collectors will be trained on the following: 
a) Background and purpose of the study, 
b) Sampling technique and procedures to identify households within the local 
government area 
c) How to determine eligible respondents and which respondents 
d) Importance of consent, how to administer both the consent forms and ensure 













e) Administering the questionnaire (interview skills) and data collection.  
 
6.8. Pilot Study 
 
A field pre-test of the survey procedures will be conducted in one of the EAs in a 
neighbouring the Local Government Area. Twenty households will be randomly selected for 
the pilot study. The team will practice performing the household listing, conducting 
interviews and testing procedures. The pilot study will serve to pre-test the questionnaires, to 
check for comprehension of questions, ease or difficulty of statements, confidence in 
response, level of discomfort and social desirability. The pilot study will also help to identify 
the various anti-malarial drug types available in the study area. The questionnaire will be 
adapted based on the results from the pre-test.  
6.9. Data management and quality checks  
The PI will check the completed questionnaires for errors and inconsistencies. A data 
manager will develop the screens using Epidata 1 for data entry and enter the questionnaires. 
The data will be further cleaned by the PI by running frequencies and cross tabulations using 
STATA 10 statistical software to identify outliers and checking for consistency among 
variables.  
6.10. Data Analysis 
Two complementary methods will be used in the analysis using STATA 10 statistical 
software. The first is the analysis of survey outcomes by descriptive statistics using 
frequencies and proportions, and the second will use the multinomial logit model to explain 
the relationship between the factors identified and the sources of treatment. The multinomial 




Descriptive analysis will be used to describe demographic and social-economic 
characteristics of households, malaria treatment seeking behaviour and anti-malarial drug 
patterns. The analyses will be presented as frequencies, means and percentages. Cross 













economic and demographic characteristics in the treatment seeking behaviour and anti-
malarial drug use patterns.  
Multinomial logit model 
A multinomial logit model will be used to assess the determinant/predictors of malaria 
treatment seeking behaviour.  This model will be used because the dependent variable (type 
of treatment that was sort) is a categorical variable with various unordered response 
categories (“public facility”, “private facility” and “did not seek care from any facility”). The 
outcome of interest (dependent variable) includes: Did not seek care at any health facility = 0, 
1= Public health facility, 2= Private health facility and 3= self treated. 
  
6.11. Model specification (Determinants of malaria treatment seeking behaviour) 
 
A multinomial logit model will be used to assess the predictors of type of care that was sort, 
and the anti-malarial drug used.  The Multinomial model is appropriate for this analysis as it 
uses the Maximum Likelihood Estimation (MLE) method to establish the likelihood that an 
individual utilized a particular type of health care provider when he/she had malaria.  
The models is based on random utility theory, where individuals (i) who report in the 
questionnaire that a member of their household had malaria symptoms are assumed to choose 
the treatment alternative (j) with the highest utility. Individuals choose between four 
alternatives: self-care, hospital, health centre, and other provider (including PMV, pharmacy, 
or drug stores). The multinomial discrete choice model assumes that the unobserved factors 
that influence the decision are the same across all alternatives and do not depend on the 
alternatives.  In this model, the probability (p) of an individual i to choose an outcome j (e.g. 
self treatment over public health facility or private health facility/provider) is given below. 
The multinomial logit model in which the probability of an individual i to choose an outcome 
j is given by: 
 
 
The coefficients (βj) on the independent variables that vary across individuals (xi) are 
allowed to vary across the choices, j. 
The coefficients (γ) on the variables that vary across the choices and perhaps across 
individuals (zij) are constant. 
 













The type of anti-malarial drug used will be classified into: ACT, AMT, CQ, SP, & Herbal 
medications. In the analysis these will be categorized as ACTs, artesunate monotherapies and 
non ACTs. A multinomial logit model as described above will also be used to determine the 
probability of using any of the anti-malarial drugs for the treatment of malaria.   
6.12. Explanatory variables/Independent variables
	
The explanatory variables that will be indentified from the literature review will be used. 
These could include: Asset index, ownership of medical insurance, household head level of 
education, Tribe, employment status, Gender, Age, Marital status, Gender of Household 
Head, Household Size, & Religion. 
7.  Ethical Consideration
 
The protocol will be submitted to the Research Ethics Committee at the University of Cape 
Town for review and approval before commencement of the study. Consent will be sought at 
three levels – the local government, community and the household level. The purpose of the 
study, procedures that will be involved, the risks and benefits of participation and the right to 
withdraw from the study at any point in time will be explained to all the participants. A 
potential risk in the study is the disclosure of information on household assets and 
possessions. People may feel uneasy or may not be willing to reveal their assets. In order to 
ensure anonymity and to avoid violations of the participants’ privacy, the questionnaire will 
not contain names of the respondents. Also, the participants will be assured that they will not 
be identified in any report or publication on the study.  
The consent forms will be translated into Yoruba- the indigenous language in Lagos State. 
Verbal consent will be received from those who are not able to read or write. The consent 
will be explicit on the purpose of the study, the harms and the benefits of the study and the 
voluntary nature of the study so that the participants can make an informed decision. 
8. Dissemination
 
The findings of the study will be made available to the Swedish International Development 
Agency and the Health Economics Unit of the University of Cape Town. Also, the researcher 
intends publish the study in any relevant academic journals and present at relevant 
conferences and academic workshops. The findings will also be presented to the Mushin 
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Successful malaria control depends greatly on prompt treatment with efficacious anti-malarial 
drugs. Artemisinin-based combination therapies (ACTs), considered the best current 
treatment for malaria are now the officially recommended treatment for malaria in most 
malaria-endemic countries.  However, there are challenges in the implementation of this 
change in anti-malarial drug policy. This literature review aims to provide information on 
treatment seeking patterns for malaria and also provide information on access to ACTs for 
treating malaria. 
 A search of Medline was conducted to identify relevant studies that evaluated malaria 
treatment seeking patterns and also studies that provided information on access to ACTs for 
treating uncomplicated malaria. The included studies varied in terms of the study design, 
method of sampling, sample sizes, etc. Some of the studies used qualitative or quantitative 
methods while others used a combination of qualitative and quantitative methods. Also, the 
findings varied across studies, even from studies conducted in the same country.  
Various treatment options for malaria were identified: No treatment, use of traditional forms 
of treatment, self treatment at home, treatment from formal health facilities (private of public 
clinics/hospitals) and treatment by purchasing anti-malarial from drug stores. About 4% to 
31% of people did not seek any form of treatment. In some of the studies, self treatment at 
home was found to be very common. Up to 80% of people self-treated at home using 
available medications found at home or bought from drug stores without prescription in some 
settings. Traditional treatments were an important source of treatment only in few of the 
studies from Bangladesh, Burundi, and India where up to 30% of people used traditional 
forms of treatment. Use of formal sources of treatment varied across location and studies. 
Some of the factors influencing the choice of treatment were: perceived severity of illness, 
socioeconomic status, cost of treatment, distance to health facility, level of education, and the 
perceived quality of treatment. Some studies also provided information on the proportion of 
people who sought treatment within 24hours or within 48hours of the onset of symptoms. 
The proportion of people that sought treatment within 24hours ranged from about 9% to 61%, 













Many of the studies were conducted before the change in treatment policy to ACTs and very 
few of those conducted after the change provided information on anti-malarial drug use 
patterns or the proportion of people that use ACT for treating malaria.  
There is limited information on household/individual level of awareness and adherence to the 
current ACT policy. Because most treatments for malaria occur at the household level, it will 
be important to explore the household level of awareness of the current policy and also 
determine the proportion of people that currently use ACTs for treating malaria. In addition 
to providing information on how socioeconomic and demographic factors influence treatment 
seeking patterns for malaria, this review has identified that there is limited information on 
household awareness of the current treatment policy and also limited information on the 





















































Malaria is a major cause of morbidity and mortality, especially among children and pregnant 
women in Africa (Snow et al. 2005).  In Nigeria, at least 300,000 children die of malaria 
annually.  Malaria is responsible for 60% of outpatients' visits, 30% of childhood mortality, 
25% of infant mortality and 11 per cent of maternal deaths in Nigeria (Federal Ministry of 
Health 2005). According to the World Health Organization (WHO), Nigeria accounts for a 
quarter of all malaria cases in the African Region and there is no evidence of any systematic 
decline in the burden (WHO 2008). This is despite a progressive increase in funds that has 
gone into the control of malaria in the country. It has been estimated that between 3-11% of 
annual household income could be lost due to malaria from both lost workdays and treatment 
and control expenditures (Leighton & Foster 1993). 
Evidence has shown that the affordable and widely available anti-malarial – chloroquine 
(CQ) – which was the major first line drug has lost its efficacy due to the emergence of CQ-
resistant strains of Plasmodium falciparum. Artemisinin based combination therapies 
(ACTs)2 have been shown to be highly effective at treating P. falciparum in most places 
where they have been studied. The WHO in April 2001 recommended the use of ACTs as 
first-line anti-malarial in countries where Plasmodium falciparum malaria is resistant to CQ, 
SP and amodiaquine (WHO 2006, Sinclair et al. 2009). In Nigeria, a nationwide surveillance 
data on efficacy showed that CQ and SP are no longer effective treatment options for malaria 
(Federal Ministry of Health 2005). 
In 2004, the federal government of Nigeria in compliance with the WHO recommendation 
banned the use of CQ and SP as first line drugs in the treatment of malaria. ACTs became the 
recommended first-line drugs for the treatment of uncomplicated malaria in Nigeria (Federal 
Ministry of Health 2005). 
The anti-malarial treatment policy change to ACT in Nigeria is expected to change malaria 
treatment and drug consumption patterns from the use of cheaper but ineffective drugs such 
                                                 
2 An ACTs is a combination of artemisinin (or one of its derivatives) with another anti-














as CQ and SPs to the use of ACTs. However, in Nigeria, the proportion of people that have 
access to effective malaria medications and that use the recommended ACTs is not known 
(World Health Organization 2009).  
In order to make ACTs accessible and affordable, the global community is considering the 
setting up of a global subsidy mechanism with funding from the Global Fund, the U.S. 
President’s Malaria Initiative, the World Bank, and others.  This is reflected in substantial 
progress many countries have made in delivering ACTs to patients through public health 
systems (UNICEF 2009). Studies on treatment seeking behaviour and anti-malarial drug use 
patterns are needed to guide strategies to ensure access to effective malaria treatments for all.  
Access can be viewed as a multi dimensional concept. The three common dimensions of 
access include availability (sometimes referred to as physical or spatial access), affordability 
(sometimes referred to as financial access) and acceptability (sometimes referred to as 
cultural access) (McIntyre & Mooney 2007, Andersen et al. 1983, Vollman 2002). 
Accessibility to effective treatment plays a significant part in health seeking behaviour. 
Differences in access between individuals may therefore provide a potential explanation for 
differences in health seeking behaviour. Prompt access to treatment with effective anti-
malarial drugs is essential to the control and elimination of malaria, and to reducing child and 
adult mortality (Hopkins et al. 2009).  ACTs have been shown to be effective both in sub-
Saharan Africa and in areas with multi-drug resistant P. falciparum in South East Asia 
(Björkman 2002). Widespread use of ACTs in South Africa has reduced the burden of 
malaria significantly (Muheki et al. 2004).  Even though the ACTs are currently a major tool 
to combat malaria, access to ACTs is still low in many countries (WHO 2008). Access to 
ACTs is critical for optimal compliance to the new treatment strategy and efforts have been 
made to improve the availability of these medications and to encourage their correct use 
(Bate et al. 2008).  
In Nigeria, the National Malaria Control Programme (NMCP) delivered 4.5 million courses 
of ACT in 2006 and 9 million in 2007 and this was far below total requirements (WHO 
2008). The cost of artemisinin derivatives is also a limiting factor for access and optimal use 
of ACT. Various forms of ACT are 5–10 folds more costly compared with the previously 
recommended treatments, CQ or SP (Saulo et al. 2008, ACTwatch 2008). Thus the cost of 
these drugs can be an obstacle to accessing these medications especially for the poor who are 
mostly affected by the disease. This may adversely affect scaling up of the WHO new 
treatment policy on malaria. However, a global subsidy mechanism is contemplated in order 


















The aim of this review is to use published studies to answer the following questions about 
malaria treatment seeking behaviour patterns and access to artemisinin combination therapies 
a. Where do people seek treatment for malaria? 
b. What proportion of people seek treatment within 28 or 48hours of the onset of 
fever/malaria? 
c. What proportion of people use ACTs for treating malaria? 







The literature search was done to identify studies that provided information on treatment 
seeking patterns for malaria and also studies that provided information on and access to 
ACTs. The main source of studies included in this review is PubMed3. To identify potentially 
relevant studies, an electronic search of PubMed was conducted from 1966 to July 2010.  The 
search strategy consisted of two parts. The first part identified malaria treatment seeking 
behaviour, while the second part focused on access to ACTs. For relevant unpublished data 
and reports, a google4 search was conducted. Also, a scan of the reference lists from 
identified studies, abstracts and previous reviews was done to identify any other relevant 
studies. All the studies included in this review reported information on malaria treatment 
seeking behavior or access to ACTs or both.  
Studies on malaria treatment seeking behaviour were identified using the search terms: 
Malaria treatment OR Treatment seeking behavior OR behaviour Treatment seeking patterns, 
Health seeking behavior OR behaviour Home management of malaria Self-treatment, OR no 
treatment for malaria , anti-malarial drug use OR Access to anti-malarial/malaria drugs OR 
medicines OR medications. The search terms used to identify studies on access to ACTs 
were: access, affordability, availability, acceptability, artemisinin combination therapy, ACTs 


















and malaria. The ‘AND’ and ‘OR’ command were used to combine the words appropriately. 
All the terms were searched in PubMed as word in text, title and abstract and as MESH 
terms. 
 
Selection of studies & criteria for including studies in this review 
 
The studies identified for inclusion had to meet the following criteria:  
 the study is about malaria treatment seeking behaviour or access to ACTs or both 
 the study describes original data  
 the study is published in English 
All studies that meet the above criteria were included irrespective of the country where they 
were conducted. The abstracts were assessed for eligibility by using these set criteria. 
Initial scan of the titles and abstracts of the search output from Pubmed was done to identify 
studies that met the above criteria. Full text articles of potentially eligible studies were 





The following data were extracted from the identified studies: setting (country) where the 
study was conducted, date of data collection and year of publication, study design (data 
collection method), sample size (if applicable), characteristics of study participants, key 
findings in relation to treatment seeking behaviour and access to ACTs. 
Treatment seeking behaviour although frequently used was never clearly defined in the 
included studies. From the results sections of the reviewed articles, all items that were related 
to the concept of malaria treatment seeking behaviour were identified. To prevent loss of 
information from any of the studies, themes that did not fall under any of these items, but are 
relevant, were reported separately. All the articles included in the review reported a wide 
variety of themes that were considered to be various forms of treatment seeking behaviour. 
The different themes were classified as follows: 
 No treatment 
 Self Treatment/Home treatment or home management of malaria 
 Use of herbal medications or traditional medications 
 Use of formal health care facilities (private and government clinics/hospitals) 














For the purpose of this review, the formal sources refer to both private and public health facilities (hospitals, 
clinics & community health centres). Informal sources of treatment refer to self treatment at home, purchasing 
medications from drug stores or patent medicine vendors (PMVs) without prescription, and the use of traditional 
forms of treatment.  
In general, treatment-seeking patterns were different across the included studies and across 
settings. 
Description of studies 
 
The included studies varied in terms of the methodologies and study findings. They used 
either quantitative cross-sectional (analytic or descriptive), qualitative studies (focus group 
discussions and in-depth interviews) or a combination of both. Most of the studies used 
collected primary data using interviewer administered structured questionnaires. A few 
studies used retrospective data from national demographic and health surveys (Kazembe et al. 
2007, Frankel & Lalou 2009).  
In keeping with the inclusion criteria, studies conducted in various parts of the world, 
including Africa, South America and Asia were included. Most of the studies provided some 
information on treatment seeking behaviour for malaria. Only a few studies provided 
information on access to ACTs and reported the proportion of people who used any form of 
ACT for the treatment of malaria (Gitonga et al. 2008, Adjei et al. 2009, Tipke et al. 2009, 
Ajayi et al. 2008, Yeung et al. 2008). None of the studies conducted before change in the 
first-line anti-malarial to ACTs provided any information on access to ACTs or the use of 
ACTs for treating malaria.  
The recall period for the treatment option taken varied across various studies and it ranged 
from two weeks for most of the studies to 6 months (Sumba et al. 2008) preceding the date of 





A total of 609 studies were identified from the search, and 466 did not meet the inclusion 
criteria.  A total of 123 full texts were further assessed for relevance to be included in this 
review. From these, 115 studies reported information on malaria treatment seeking behaviour, 
access to ACTs or both. All the studies identified from Google were also found in the 
Pubmed search. The included studies studies were conducted in different countries across 








































Treatment seeking Behaviour 
 
Early diagnosis and prompt treatment has been a cornerstone of malaria control (Snow et al. 2005). Various 
patterns of malaria treatment-seeking were documented in the included studies. These included both the formal 
and the informal sectors, with self treatment at home in some cases. The various forms of treatment seeking 
patterns identified were: o treatment, self-treatment at home with any available medication, purchasing 
medications from drug stores or PMVs, use of private or public health facilities, and use of traditional forms of 
treatment. 
Most of the studies reviewed indicate that most people do not use laboratory services for the 
diagnosis of malaria. Self diagnosis and self treatment at home have been noted to be 
common (McCombie 2002). Also, the use of ineffective drugs in Sub Saharan Africa, in 
recent years has led to treatment failures and elevated rates of mortality, particularly among 


























Few of the studies provided information on the proportion of people with malaria who did not 
seek any form of treatment (see Table 1 below). The proportion varied across studies ranging 
from 3.6% (Salako et al. 2001) to 31% (Ahmed et al. 2009).  
 
Table 1: Proportion of cases who did not seek any form of treatment 
 
Country % with no 
treatment 
Comment Sample size Year & type of 
study  
Author & year of 
publication 





(Ahmed et al.  
2009) 








(Deressa & Ali 
2009) 





2003, Quantitative  
C-Survey 
(Wiseman et al. 
2008) 
Kenya 9%  883 mothers  (Mwenesi  1995b) 
Kenya  28.1% Overall from 4 
districts 






(Amin et al. 2003) 





(Hamel et al. 
2001b) 
Kenya 21%  138 cases of 
febrile 
illness,
1991, Quantitative  
C-survey 
(Ruebush et al. 
1995) 




(Salako et al. 2001) 
C-survey: cross-sectional survey 
 
Self treatment or Home Treatment 
 
Self or home treatment is defined as involving the use of any medication before or in the 
absence of a visit to a health facility and without prescription (Deressa 2003, McCombie 
2002). Self-treatment with anti-malarial is rampant in malaria endemic countries. A survey 
(not listed in the table) of 21 African countries revealed that of those who treated febrile 
illness with anti-malarial, 46% obtained treatment at a health facility, 44% at home and 10% 















Table 2: Proportion of people who used self- or home- treatment  
 
Country % self/home 
treatment 
Comment Sample size Year & type of  
study  
Author & year of 
publication 
Bangladesh 40%  9750 
individuals  
July-Nov 2007 (Ahmed et al. 2009) 
Burkina Faso 41%  to 46% Two localities 1052 
households 
Feb/March 2006 (Tipke et al. 2009) 




709 children Data set from 
RCT, 1999 
(Müller et al. 2003) 





(Deressa & Ali. 2003) 





2003, C-survey (Wiseman et al. 2008) 
Guyana 15%  256 
individuals 
May 10 through 
June 6 1999, C-
survey 
(Booth  2001) 
Indonesia 18%  1000 
households 
May to July 
2001, C-survey 
(Sanjana et al. 2006) 





(Chaturvedi et al.. 2009) 




























(Dev et al. 2006a) 
Kenya 47%  670 
households 
July 1996,  
Quantitative  C-
survey 
(Hamel et al. 2001b) 
Kenya 12% Comparison 
between an urban 
and rural area 
248 lifelong 





(Molyneux et al. 1999) 





(Ruebush et al. 1995) 
Malawi 27% Data from DHS 4,245 care-
givers  






(Kazembe et al. 2007) 




















Mali 87%  952 children Quantitative  C-
survey
(Diallo et al. 2006) 
Mali 75.8%  399 mothers Quantitative  C-
survey 
(Diallo et al. 2006) 






Nigeria 19.3%  300 care 
givers 
November 




(Okeke & Okafor 2008) 
Nigeria 6.3%, 9.6%, 
6.2%, 5.2% 





 (Onwujekwe et al. 2008b) 
Nigeria 60.2%  186 mothers May-September) 




(Akogun & John 2005) 





(Oguonu et al. 2005b) 














(Agu & Nwojiji 2005) 






(Donnelly et al.  1997) 






(Frankel & Lalou 2009) 








(Hetzel et al. 2008a) 
C-survey: cross-sectional survey 
 
 
The included studies had varying findings on the proportion of people who treated 
themselves at home without any visit to health facilities. The summary of the various findings 
are shown in table 2 above. A household survey in central Ethiopia revealed that about 18% 
of people suffering from malaria self-treated at home (Deressa & Ali 2003). In similar studies 
in Sudan and Burkina Faso, it was found that people usually start care at home and then shift 
to health workers if there was no response (Malik et al. 2006, Pfeiffer et al. 2008).The 
findings were similar in Guatemala, Malawi, Mali, and Kenya, where more than 60% of the 













studies conducted in Burkina Faso, Mali, Nigeria and India, show that more than 70% of 
children with fever were treated at home (Diallo et al. 2006, Muller et al. 2003, Oguonu et al. 
2005b Yadav et al. 2007). It is important to note that some of that some people self treated at 
home by purchasing drugs from drug stores and retailers. 
 
 Table 3: Proportion of people who used Traditional treatments 
 
Country % with 
traditional 
treatment 
Comment Sample size Year & type of 
study  
Author & year of 
publication 





(Ahmed et al. 2009) 






(Tipke et al. 2009) 
Burundi 39.9% Traditional or 
no treatment 
526 children July-August 
2004, C-survey 
(Gerstl et al. 2007) 





(Deressa & et al. 2003) 





(Chaturvedi et al. 2009) 
Kenya 7%  883 mothers Quantitative  C-
survey 
(Mwenesi et al. 1995b) 
Kenya 3%  670 
households 
July 1996,  
Quantitative  C-
survey 
(Hamel et al. 2001b) 
Mali 27%  952 children Quantitative  C-
survey
(Diallo et al. 2006) 














to April 2005, 
Quantitative  C-
survey 
(Joshi & Banjara 2008) 







(Donnelly et al.1997) 




(Mnyika et al. 1995). 
 
The use of traditional sources of treatment or herbal medications at home ranged from 3% 













were an important source of treatment only in few of the studies from Bangladesh, Burundi, 
India, Mali and Pakistan, where more than 20% of cases used traditional sources of treatment. 
One of the studies from India showed that traditional healers were the second most important 
source of treatment after self medication at home (Chaturvedi et al. 2009). In Mali more than 
30% of children were treated at home with a mixture of modern and traditional medicines 
(Diallo et al. 2006). Similarly a qualitative study in Uganda showed that people usually 
mentioned the use of herbs as the first treatment action, followed by the purchase of tablets 
from shops, with the final recourse being the formal health sector if the previous actions had 
not effected a cure (Kengeya-Kayondo et al. 1994). 
A small proportion (less than 10%) of people with fever/malaria resorted to traditional forms 
of treatment in Kenya (Hamel et al. 2001, Mwenesi et al. 1995), Ethiopia (Deressa et al. 
2003) and Sudan (Malik et al. 2006). 
Treatment by purchasing drug from informal drug stores or PMV 
 
A considerable number of the studies found that self treated at home usually by purchasing 
medicines from private medicines stores and vendors (PMV) or by using locally prepared 
concoction. Several studies in Nigeria found that PMVs are the most common source of 
malaria treatment for many households (Salako et al. 2001, Uzochukwu & Onwujekwe 2004, 
Agu & Nwojiji 2005, Oguonu et al. 2005b, Onwujekwe et al. 2008, Enato & Okhamafe 2006, 
Onwujekwe et al. 2006). The findings were similar in studies from Uganda, Malawi, Kenya 
and Bangladesh (Kazembe et al. 2007, Oryema-Lalobo 2009, Tumwesigire & Watson 2002). 
Also, studies from Ghana and Cambodia found that more than 60% of cases purchased 
medications from drug stores without prescriptions (Yeung et al. 2008, Ahorlu et al. 2006a). 
Surveys from Kenya showed that the most common actions were the purchasing of over the 
counter drugs at retail outlets (Mwenesi et al. 1995, Molyneux et al. 1999, Snow et al. 1992). 
In Malawi it was found that up to 35% of care-givers of children with fever obtained drugs 
over the counter (Kazembe et al. 2007). A study from Lao People's Democratic Republic (not 
listed in the table) found that only a small proportion of people used informal retailers and 























Table 4: Proportion of people who used purchased drug from informal drug stores 
 
Country % with no 
treatment 
Comment Sample size Year study was 
conducted
Author & year 
of publication
Bangladesh 12%  9750 individuals July-Nov 2007, 
Quantitative  C-
survey 
(Ahmed et al. 
2009) 
Cambodia 63%  1491 households 
in 23 settlements 
2002, Quantitative  
C-survey 
(Yeung et al. 
2008b) 
Gambia 1.44% Self care & no 
treatment were 
combined 
1700 households 2003, Quantitative  
C-Survey 
(Wiseman et al. 
2008) 
Ghana 67%  100 caretakers of 
children up to 5 
years of age 
October 2002 to 
April 2004, both 
Quantitative  C-
survey 










869 householders 2002–2003, 
Quantitative  C-
survey 
(Dev et al. 2006a) 
Kenya 19.0% of adults 




120 households August-September, 
2002,  Quantitative  
C-survey 
(Sumba et al. 
2008b) 
Kenya 26.1% From four 
communities 





(Amin et al. 
2003) 
Kenya 47% Comparison 
between an 
urban and rural 
area 
248 lifelong rural 




(Molyneux et al. 
1999) 
Kenya 72%  388 mothers Quantitative  C-
survey 
(Snow et al. 
1992) 
Malawi 35% Data from DHS 4,245 care-givers  based on the 2000 
Malawi demographic 
and health survey, 
Quantitative  C-
survey 
(Kazembe et al. 
2007) 











Nigeria 46% Rural 
community
408 individuals 2006, Quantitative  
C-survey
(Oguonu et al. 
2005b) 










Nigeria 13.6%%  250 households Quantitative C-
survey 
(Agu & Nwojiji 
2005) 




(Salako et al. 
2001) 













households survey 2009) 






C-survey: cross-sectional survey 
A study on the role of PMVs in three regions in Nigeria showed that PMVs still provided 
medications that are no longer recommended: 92% (72%) of shops had SP and CQ in stock.  
The PMVs have been observed to behave primarily as commercial salesmen, since around 
75% simply sell what a customer requests, and on other rare occasions, fills a prescription 
(Brieger et al. 2004). There are concerns that the PMVs have little knowledge about new 
guidelines for malaria treatment and they still recommend that people use ineffective anti-
malarial. There are also concerns about the quality of the drugs that are supplied by the 
PMVs (Oladepo et al. 2007).  
Formal sources of treatments 
 
Formal health facilities refer the use of government or private hospitals and clinics, and 
community health centre or trained village health workers. The proportion of people that used 
formal health facilities as initial or secondary source of care varied in the different studies. 
The studies differed in the way the findings were presented. In some, the authors did not 
differentiate the type of formal health facility (public versus private) that was used. In these 
studies, all the people that sought care from any hospital, clinic or health facility were 
grouped under the same category. Also some of the studies compared the proportion of 
people that sought care from the various sources across different communities, age groups 
(children versus adults), or urban versus rural areas.  Table 5 shows the proportion of people 
that used public, private clinics/hospitals and community health centres.  Many of the 
included studies showed that patients resort to external care from public or private facilities 
only after home remedies have failed. Some of the studies conducted in Kenya, Philippines, 
Tanzania, and Zimbabwe revealed that public health facilities were usually the first choice 
when people sought external care (see table 5). Also, findings from Ethiopia and Uganda 
showed more than 60% of cases received initial treatment from formal health facilities 
(Paulander et al. 2009, Lindblade et al. 2000). In Pakistan it was found that a great proportion 
of people exclusively used private hospitals because private care providers were perceived to 
be rendering better quality particularly (Donnelly et al. 1997) . In areas where treatment was 
provided free at public health facilities, a greater number of people consulted public health 
facilities for the treatment of malaria. This was the finding from two studies conducted in 













One of the studies from Ethiopia showed that up to 98% of cases used public health facilities 
because treatment standards were perceived to be very high (Paulander et al. 2009). This 
results contrast findings from other studies in Ethiopia (Deressa 2007) and other African 
countries (Müller et al. 2003, Molyneux et al. 1999, Gerstl et al. 2007, Onwujekwe et al. 
2008). Evidence from various studies in Nigeria shows that for both children and adults, the 
use of public or private hospitals for the treatment of malaria is low.  Also, most of the 
treatments occur in the private sector by purchasing drugs from patent medicine vendors 
(Oladepo et al. 2007).  However, in one of the studies from Nigeria, the health centre was the 
most preferred choice (21%) where treatment was first sought (Agu & Nwojiji 2005). This 
was because of close proximity to the health centre. In Burkina Faso only about 1% of people 
reporting malaria sought care from a hospital. 
 










Comment Sample size Year & type 
of study  




1%  16%  1,052 
households 




(Müller et al. 2003) 




(Gerstl et al. 2007) 
Cote 
d'Ivoire 
33%  232 households 1999 to 2003, 
Quantitative  
C-survey 
(Esse et al. 2008) 
Ethiopia <40% 21%  2087 rural 
women with 
children less 






(Deressa & Ali  
2009) 










(Paulander et al. 
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Guyana 96%  256 individuals May 10 







30% 20  1,000 
households in 50 
villages 




(Sanjana et al. 2006) 




(Chaturvedi et al. 
2009) 
India 23.4% 9%  205 Quantitative  
C-survey 







88.9% 6.7% Treatment 
was free in 
government 
hospitals 
869 householder 2002–2003, 
Quantitative  
C-survey 
(Dev et al. 2006) 
Kenya 66.0% and children (66.7%) Adults vs. 
children 





(Sumba et al. 2008) 
Kenya 47%   Quantitative  
C-survey 
(Guyatt & Snow 
2004) 
Kenya 29.5% From four 
communities 






(Amin et al. 2003) 
Kenya 43%  6%  670 households July 1996,  
Quantitative  
C-survey 
(Hamel et al. 2001) 










(Molyneux et al. 
1999) 


























(Onwujekwe et al. 
2008) 









Nigeria 15.9% 10.2% 21%  250 households Quantitative 
C-survey 
(Agu & Nwojiji 
2005) 












































(Malik et al. 2006b) 







(Hetzel et al. 2008a) 
Tanzania 84%  729 households Quantitative  
C-survey 
(Eriksen et al. 2005) 
Tanzania 62.5% vs. 33.3% Children vs. 
adults 




(Hetzel et al. 2008b) 
Turkey 53.5%  318 individuals October 2002, 
Quantitative  
C-survey 
(Simsek & Kurcer 
2005) 







Uganda 65%  300 households Qualitative C-
survey 
Lindblade et al. 2000 
C-survey: cross-sectional survey 
Treatment within 24 or 48 hours of onset of fever 
 
As part of the Roll Back Malaria initiative, African heads of state have pledged that by 2005, 
60% of children will receive an effective anti-malarial drug within 24 hours of developing 
fever. Some of the studies reported the proportion of cases seeking treatment within 24 hours 
of onset of fever. The proportions for each of these studies are summarized in table 6.  It 
varies from 8.6% (Dev et al. 2006) to 68% (Hamel et al. 2001). A study in Guyana found that 
80% of individuals waited for longer than 1 day before seeking any form of treatment. The 
reasons for the delay varied from lack of transportation to health facilities, to perceived 
severity of symptoms (Booth 2001). The findings were similar with that from another study 








































Comment Sample size Year & type of 
study 
Author & year 
of publication 





(Ahmed et al, 
2009) 




(Tipke et al, 
2009) 





Ghana 11% 33%  100 caretakers 
of children up 
to 5 years of 
age 
October 2002 to 




(Ahorlu et al. 
2006) 
Guyana 20%   256 individuals May 10 through 












(Dev et al 2006) 
Kenya 68.0% v. 
48.5% 






(Sumba et al. 
2008) 








(Gitonga et al. 
2008) 




(Hamel et al. 
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(Mustafa et al. 
2009) 
Tanzania 35.0% vs.  42.1% children vs. 
adults 
318 households May- August 
2004 




























(Amuge et al. 
2004) 
Uganda 30%   1898 
individuals 





et al. 2007) 
Uganda 59%   209 rural 
peasant 
families 
May 2001 (Tumwesigire & 
Watson 2002) 
C-survey: cross-sectional survey 
 
Access to and Use of the recommended ACT 
Findings across Africa suggest that the majority of those with malaria do not get anti-
malarials, including ACTs (Whitty et al. 2008). According to the WHO, none of the 
populations of 18 African countries surveyed in 2006 and 2007 had adequate access to anti-
malarial drugs (WHO 2008). Access to treatment was not up to the 80% target in any of the 
countries, with the average across the 18 countries being 38%. The overall proportion of 
children with fever receiving anti-malarial drugs was 31% and the proportion of febrile 
children receiving anti-malarial drugs within 48 hours was 23.3% (WHO 2008). 
A study in Cambodia found that coverage of ACTs was low and that there was widespread 
use of artemisinin monotherapy (Yeung et al. 2008a). Similarly in Kenya, about one year into 
the change in treatment policy to ACT, it was found that a small proportion (about 10%) of 
children received the recommended first line ACT (Gitonga et al. 2008a). In Burkina Faso a 
study found that less than 1% of households stocked effective combination therapies for 
malaria, while about 86% of anti-malarial stocked was CQ (Tipke et al. 2009). 
 
Table 7: Proportion of people who used ACT for treating malaria fever 
 
Country % Use of ACTs Comment Sample size Year study was 
conducted 
Author & year of 
publication 






















Kenya 10.2% Proportion of 
children who 
received AL (less 








and June 2007, 
Quantitative  
C-survey 
(Gitonga et al, 2008) 
 
In Ghana it was shown that parents of children treated with ACTs were more willing to pay 
for the treatment, or adhere to the full treatment course (Adjei et al. 2009). In another study in 
Tanzania, only 50% of mothers and household heads were willing to pay for a child’s dose of 
ACT (Saulo et al. 2008b). A qualitative study using focus group discussions (FGD) in 
Nigeria found that caregivers and other members of the communities in which this study was 
conducted were very receptive to the new drug (Arthemether Lumefantrine) (Ajayi et al. 
2008b). The community members perceived artemether-lumefantrine (an ACT) to be 
effective. A facility based study in Surulere, Lagos, found a high acceptance for ACT 
products (Joda & Fanimokun 2008). These findings suggest that the use of ACTs is 
acceptable to people in various communities where it has been studied. The current problems 
with access to ACTs and use of ACTs for the treatment of malaria have to do with 
availability and affordability of the medications. 
 
Determinants of Treatment seeking Behaviour 
 
Human health care seeking behaviour, which is the action people take when dealing with an 
illness, is influenced by a multiple of factors apart from knowledge and awareness (Jain et al. 
2006). Some of these factors are predisposing characteristics such as age, gender, occupation, 
education and others enabling factors such as proximity to the health facility, health 
insurance, income and existence of social networks (Law et al. 2005). Several theoretical 
models have been used to explain the determinants of health seeking behaviour. One of these 
is the model, often called the Anderson model.  It includes 3 groups of factors, namely; 
predisposing factors, enabling factors and health services system (Andersen et al. 1995).  
Multiple barriers to accessing effective treatment for malaria have been identified. These 
barriers include perceived quality of care, lack of knowledge, distance from health services, 
transport costs, treatment costs, opportunity costs (Whitty et al. 2008, Noor et al. 2003). 
Education 
In some of the studies, the education level of the household head was found to influence 













24 hours of onset of illness (Paulander et al. 2009, Hossain et al. 2001, Simsek & Kurcer 
2005). Also, educational level has been found to be associated with malaria treatment seeking 
behaviour. A study from Ghana revealed that more literate households were more likely to 
seek care from private hospitals (Dzator & Asafu-Adjaye 2004). Various studies showed that 
higher levels of education were associated with promptness in seeking care from a health care 
provider (Tarimo et al.  1998, Tarimo et al. 2001, Slutsker et al. 1994).   
Socioeconomic status 
Socioeconomic status is another factor that has been found to affect health seeking behaviour. 
In some of the included studies it was found that those likely to delay treatment come from 
the lowest socio-economic quintile while the wealthy were more likely to seek treatment 
within one day of symptom onset, both for themselves and for their children (Sumba et al. 
2008, Rutebemberwa et al. 2009, Dev et al. 2006).  In Nigeria, studies have shown that 
poorer people are more likely to resort to self diagnosis and treatment. Also the poorer the 
respondents, the more likely they are to  use traditional healers, patent medicine dealers and 
community health workers for treatment of malaria while rich households are more likely to 
use the services of private clinics perceived to offer better quality services (Onwujekwe et al. 
2008, Uzochukwu & Onwujekwe 2004, Onwujekwe 2005). The findings are similar in Ghana 
where the proportion of caregivers who purchased drugs without prescription or used left-
over drugs to treat clinical malaria in the children was higher (82%) in the poorer community 
compared to the richer (53%).   Also, children from the poorer communities were less likely 
to have been taken to a clinic or hospital to be treated for malaria than children from the 
better-off communities (27% v. 42%) (Biritwum et al. 2000).  In Tanzania, Njau et al found 
that the coverage of appropriate malaria treatment was low in all socio-economic groups, but 
the two poorer groups were particularly disadvantaged (Njau et al. 2006).  
Cost of treatment and medical insurance 
The cost of treatment and time costs have also been shown to influence the choice of health care providers 
(Dzator & Asafu-Adjaye 2004). For example a study in Nigeria found that low cost of care was associated with 
choosing traditional healers and home treatment (Agu & Nwojiji 2005). Similarly, in Sudan the choice between the 
available options for treatment was found to be determined by user fees (Malik et al. 2006). Financial constraints 
to buy anti-malarial drugs were some of the main reasons given for failing to provide an effective anti-malarial 
treatment within the home in Malawi (Chibwana et al. 2009). Another study in India showed that people who are 
economically poor and living in remote areas mainly visit the government health service providers for seeking 
treatment, possibly due to the more expensive treatment in private health centers. (Chaturvedi et al.  2009).  
Further, people who have health micro-insurance were more likely to go for care earlier once they realized they 














Distance to health facilities 
Health facilities far away from home was one of the factors associated with delay in seeking care within 24 hours 
or not seeking care from health facilities. Many cases of fever were treated at home because health facilities 
were located far from home (Frankel & Lalou 2009, Malik et al. 2006, Onwujekwe et al. 2008, Paulander et al. 
2009, Hossain et al. 2001, Dev et al. 2006, Chibwana et al. 2009). A study conducted in Nigeria, found that 
proximity was the major factor (92.3%) that made most people seek care from the community health workers 
(Agu & Nwojiji 2005) that are closest to them. 
Perception of illness 
Findings from various studies show how local concepts of illness strongly influence treatment 
and choice of provider.  Care seeking behaviour is strongly influenced by perceptions and 
personal opinions of fever. In many places, malaria is considered as commonplace and not 
warranting care in a health centre (Tipke et al. 2009, Houeto et al. 2007, Beiersmann et al. 
2007, Reilley et al. 2002).   Some studies have found that mothers home treated or went to 
the village treatment centre, or both, if they judged it to be "natural" fever. Traditional 
treatment was thought to be best if the fever was thought to be “supernatural” or classified as 
“not-for-hospital” (Pilkington et al. 2004). Many care givers in some settings believe that 
convulsions are spiritual, not related to malaria and are best treated by traditional healers 
(Foster & Vilendrer 2009). 
Quality of service provided at health facilities 
The quality of services provided by a health facility has been found to be an important determinant of where 
people first sought treatment. Some studies in Nigeria showed that the factors that encouraged people to seek 
treatment at the health centres were the perceived good quality of services.  This is because the centres were 
near the people and that the health workers were deemed to be polite (Onwujekwe et al. 2008, Uzochukwu & 
Onwujekwe 2004). Agu and Nwojiji found that low cost of care and good personal experience were the main 
reasons for the choice of traditional healers and home treatment respectively (Agu & Nwojiji 2005). In studies 
conducted in Nepal and Sri Lanka it was found that absence of health workers in the health facilities were the reasons 
given for not visiting health facilities for the treatment during fever with chills (Joshi & Banjara 2008, Reilley et al. 2002).  
Location 
Various studies have shown that self-medication and the use of traditional remedies are commoner in rural than 
in the urban population for the treatment of malaria (Chaturvedi et al. 2009, Abdel-Hameed 2001).  Also, living in 
remote areas may be the main cause of delay in diagnosis and treatment of malaria (Chaturvedi et al. 2009, 
Singh et al 2003). A study in Ghana found that self treatment with drugs was more common in the urban areas 
(Agyepong & Manderson 1994). 
Age 
The age of the individual and that of the household head have also been found to influence 
the choice of seeking treatment.  In Uganda, respondents in child-headed households were 
less likely to seek health care from health facilities (Amuge et al. 2004). In Burkina Faso it 














Other factors include ethnicity and occupation.  In Malawi, ethnic differences were associated 
with the type of care chosen. For example, certain ethnic groups were less likely to choose 
home treatment (Kazembe et al. 2007) over formal treatment options.  Also, mothers’ 
occupation was found to influence the choice of treatment for malaria episodes (Olaogun et 
al. 2006). 
Conclusion 
It is difficult to combine and report the evidence from the included studies. The methodologies, sampling 
strategies, sample size, and methods of data collection were different across all the studies. Therefore we could 
not pool the findings together in a meta-analysis.  The findings were, therefore, presented as a narrative 
summary. However, tables are presented to show the various proportions of people that used different treatment 
options in the various studies. We included more recent studies compared to a previous literature review on 
malaria treatment seeking behaviour by McCombie (McCombie 1996); however the findings are not very different 
from the previous review. Like in the review by McCombie, the findings from the individual studies were variable; 
however, self or home treatment still remains an important treatment option for most people with malaria fever in 
many endemic areas. 
From this literature review, there is little information on the level of awareness and adherence 
to the new malaria treatment policy that recommends ACTs as first-line medication for 
treating malaria. Many of the studies including those studies from Nigeria were conducted 
before the change in treatment policy to ACT.  More than 6 years after the change in 
treatment policy in Nigeria, it is not certain if this policy is being adhered to or not. Also the 
household level of awareness of the ACTs for treating malaria in Nigeria is not known. At the 
time of this literature review, the proportion of people who use the currently recommended 
ACT in Nigeria is not known (World Health Organization 2009, McCombie 1996).    
Studies on treatment seeking behaviour and anti-malarial drug use patterns are needed to 
guide strategies to ensure access to effective malaria treatments for all. In addition to 
exploring patterns on treatment seeking behaviour for malaria, the review also aims to 
provide information on the proportion of people that use ACTs for treating malaria.  
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ACTs have been shown to be effective in treating malaria and are currently recommended as 
first-line drugs for the treatment of uncomplicated malaria in Nigeria because of resistance of 
malaria to chloroquine (CQ) and sulphadoxine pyrimethamine (SP). However, very little is 
known about malaria and treatment-seeking patterns and the use of ACTs since the adoption 
of the treatment policy more than 6 years ago in Nigeria. 
 
Methods 
A cross-sectional survey of households was conducted in Mushin local government of Lagos 
State. Households where at least one individual had a history of fever/malaria in the last four 
weeks preceding the interview were eligible for inclusion in the study. Both descriptive 
measures and the multinomial logistic regression are used to analyze the data. 
	
Results	
Most treatments for malaria occurred at household level (35.11%) with the use of available 
medications or by the purchase of medicines from drug stores (25.42%). Most of the 
respondents (78.92%) did not know which drug was used for the treatment of malaria. The 
most commonly used anti-malarial were SP (34.23%) and CQ (11.01%). Only about 6.55% 
use an ACT. About 23% of the respondents had heard of ACTs and only 4% knew ACTs 
were the currently recommended drugs for treating malaria. Among the respondents that had 
heard about ACTs, most agreed they knew where to get ACTs and that they could afford 
ACTs even though they are more expensive than SPs and CQs. The factors that were found to 




Efforts should be made towards improving the awareness of the current malaria treatment 
policy. In addition, steps need to be taken to ensure that the policy is implemented and that 

















Malaria is a major cause of morbidity and mortality, especially among children and pregnant 
women in Africa [1]. In Nigeria, at least 300,000 children die of malaria annually [2]. 
According to statistics malaria is responsible for 60% of outpatients' visits, 30% of childhood 
mortality, 25% of infant mortality and 11% of maternal deaths in Nigeria [3].  The World 
Health Organization (WHO) suggests that Nigeria accounts for a quarter of all malaria cases 
in the African Region, and there is no evidence of any systematic decline in the burden 
despite a progressive increase in funding to control it [4]. It is estimated that between 3-11% 
of annual household income could be lost due to malaria from both lost workdays and 
treatment and control expenditures [5]. 
Evidence has shown that the affordable and widely available anti-malarial – chloroquine 
(CQ) – which was the major first line drug has lost its efficacy due t  the emergence of CQ-
resistant strains of Plasmodium falciparum [3]. Artemisinin based combination therapies 
(ACTs)5 have been found to be highly effective at treating Plasmodium falciparum malaria 
in most places where they have been studied. In April 2001, the WHO recommended the use 
of ACTs in countries where P. falciparum malaria is resistant to CQ, sulphadoxine - 
pyrimethamine (SP) and amodiaquine [6]. Although ACTs are more expensive than CQ and 
SP, they are currently the WHO recommended first-line drugs for treating uncomplicated 
malaria in areas of resistance to CQ and SP [7]. However, a global subsidy mechanism is 
contemplated in order to make ACTs accessible and affordable [8]. 
In 2004, the Federal Government of Nigeria in compliance with the WHO recommendation 
banned the use of CQ and SP as first-line drugs in the treatment of malaria [3].  ACTs 
became the recommended drugs for the treatment of uncomplicated malaria in Nigeria.  
The Roll Back Malaria Partnership (RBM) set as target for 2010 that 80% of malaria patients 
are diagnosed and treated with effective anti-malarial medicines e.g. ACTs within one day of 
the onset of illness [9]. However, the proportion of people with fever/malaria that currently 
use the recommended ACTs is not known in many countries, including Nigeria [10]. Many 
studies on treatment-seeking behaviour for malaria were conducted before the adoption of 
ACTs for the treatment of malaria [11-13]. There is limited information on household 
awareness of the current treatment policy and the proportion of people that use ACTs for the 
treatment of malaria [10, 14,15]. More than 6 years after changing the treatment policy, it is 
                                                 
5 An ACTs is a combination of Artemisinin (or one of its derivatives) with another 













unknown if this policy is being adhered to or not. Studies on treatment seeking behaviour and 
anti-malarial drug use patterns are needed to guide strategies for ensuring access to effective 
malaria treatments for all. Because of the limited information on the level of awareness and 
the proportion of people that use ACTs for treating malaria, our study, therefore, seeks to 
assess household treatment-seeking behaviour for malaria and also the drug use patterns in 
this era of ACTs for treating malaria.  
 
This study seeks to answer the following questions: 
1. Where do people from different socio-economic groups seek treatment for malaria?  
2. What proportion of people used a formal malaria diagnostic test to confirm symptoms 
of malaria? 
3. What is the level of awareness of the ACTs for malaria treatment? 
4. What proportion of people use ACT for treating malaria/fever? 




This study was carried out between November and December 2009 in Mushin Local 
Government Area (LGA) of Lagos State, South West Nigeria. According to the 2006 national 
census, Lagos State though small in land mass, is one of the most populous States in Nigeria 
with a population of over 9 million inhabitants.  Lagos has 20 Local Governments Areas 
(LGAs) and 37 Local Council Development Areas created to bring governance, development 
and participatory democracy nearer to the people [2]. Mushin is a local suburb of Lagos State 
and also one of the 20 LGAs with a population of 633,009 [2]. It is located 10 km north of the 
Lagos city core, and is a largely a congested residential area with inadequate sanitation and 
low-quality housing. The people are predominantly traders and artisans from various ethnic 
groups in Nigeria. The major ethnic groups are Yoruba and Igbo and the major religions are 
Islam and Christianity.   Mushin is the home of Lagos University Teaching Hospital (LUTH) 
and also the Mushin General Hospital. The study area was purposively selected based on the 
primary researcher’s familiarity with the area.  This allowed for easy access to households for 














Interviewer administered structured questionnaires were used to collect data from household 
heads or caregivers by trained interviewers. The questionnaire was developed and piloted in 
20 households in a neighboring LGA. The original questionnaire was reviewed and modified 
based on the findings from the pilot study. Only households that had at least one person with 




One of the key indicators of malaria treatment seeking behaviour is the proportion of the 
population that used effective treatment options for malaria. Therefore, the sample for this 
study was calculated based on “the proportion of fever/malaria episodes in the 4 weeks 
preceding the survey that used an ACT for treatment within 24 hours of the onset of fever” 
(as recommended by the RBM Partnership) At the time when this study was conducted there 
was no information on the proportion of people that use the recommended ACT for the 
treatment of malaria in Nigeria [10]. Therefore we assumed a proportion of 50% and 
calculated a sample size of 422 households. A total of 422 households were where at least  
one person (irrespective of age) had an episode of malaria 4 weeks preceding the date of 
interview.   
Data collected include household demographic and socio-economic characteristics, level of 
respondent’s knowledge regarding the recommended anti-malarial, malaria treatment seeking 
behaviour, and anti-malarial drug use. 
 
Data entry and analysis 
Data was double entered into Epidata 2000, checked for inconsistencies, cleaned and 
analyzed using STATA© (Version 10). Two complementary methods are used in the analysis. 
The first was the analysis of survey outcomes by descriptive statistics using frequencies and 
proportions, while the second method was analytic, using the multinomial logit model. The 
descriptive analysis provides information on the proportion of people that used various 
treatment options, while the multinomial logit model provides information on the factors that 
influence the treatment choices. This multinomial logit model was used because the 
dependent variables (source of treatment and antimalarial drug used) are categorical 













were classified into: informal sources (comprising self-medication, drug stores (PMVs) and 
use of traditional healers), government, and private facilities. The last antimalarial medication 
that was used for treating the fever was classified into: ACTs, artesunate monotherapy, and 
others (comprising chloroquine, sulphadoxine pyrimethamine, and quinine). From the 
literature review, the ‘determining’ variables that were identified include: household asset 
index (or wealth), ownership of medical insurance, level of education of household head, 
tribe (or ethnicity), employment status, gender, age, marital status, household size, and 
religion. Individuals suffering from malaria were used as the unit of analysis. An index of 
socio-economic status was constructed through the Principal Components Analysis (PCA) 
technique using ownership of household assets [16]. The assets used include motorcycle, car 
or truck, video or DVD player, refrigerator, cable or satellite TV, mobile phone, generator 
and nature of dwellings. The index was further categorised to generate five socio-economic 
groups or quintiles from the most poor to the least poor. 
Ethical aspects 
Ethical approval was obtained from the Mushin LGA and the University of Cape Town, 
South Africa. Informed consent was obtained from all respondents after explaining the 
purpose and objectives of the study. In order to ensure anonymity and to avoid violations of 
the participants’ privacy, the questionnaires did not contain names of the respondents. Also, 
the participants were assured that they will not be identified in any report or publication on 





A total of 408 questionnaires (97%) were successfully completed. The 408 households 
consisted of 1672 individuals, with an average household size of 4 persons. The general 
characteristics of household heads such as sex, education, occupation, tribe, religion, marital 




















Table 8: Demographic and socioeconomic characteristics of household heads 
Variable Category Number % of sample 
Sex Male  344         84.31 
Female  64         15.69 
Total 408 100 
Age (years) Mean 45, Range (20 to 80) 
 
Level of education  None 30 7.35 
Primary 92 22.55 
Secondary 216 52.94 
Tertiary 63 15.44 
Don’t know 7 1.72 
    








Unemployed 27 6.62 
 
Marital  Married 332 81.37 
Divorced 2 0.49 
Separated 6 1.47 
Widowed 31 7.60 
Never married 37 9.07 
 
Religion Christian 226 55.39 
Muslim 182 44.61 
 
Ethnic origin Yoruba 322 78.92 
Igbo 70 17.16 
Hausa 2 0.49 




Yes  8          1.96 




Most of the household heads were males (84.31%). Slightly over half (52.9%) of the 
household heads had completed secondary education and about 15.4% reported that they had 
tertiary education. About 55.4% of the study participants practise Christianity and 44.61% 
Islam. This is similar to the proportions reported in the general population of Lagos. Most of 













included Hausa, Edo, and Calabar. Only about 1.96% of the household heads owned any 
form of health insurance.   
Table 2 below shows some of the characteristics of the people that had a history of 
fever/malaria within the previous 4 weeks preceding the interview date.  
 
Table 9 Demographic characteristics of individuals that had fever/malaria  
Variable Category Number % of sample 
Sex Male 188 45.52 
Female 225 54.48 
Total 413 100 
Age < 5 years 18 5% 
5 to 15 year 45 11% 
> 15 years 350 85% 
Education level  None 45 10.90 
Primary 115 27.85 
Secondary 217 52.54 
Tertiary 35 8.47 
Don’t know 1 0.24 












Only about 24% of the respondents the 408 respondents had heard about any of the ACTs. 
When asked about what anti-malarial drug is currently recommended as first-line, 77% of the 
respondents did not know, 4% mentioned a brand of SP, about 3% mentioned ACTs and 3% 





     
 
















   Figure 2 Respondents' awareness of artemisinin combination therapy 
 
 



















About 24.7% of the sample had a history of fever/malaria in the previous four weeks 
preceding the interview date (see Table 3 below). Symptoms reported to be associated with 
the fever included loss of appetite, vomiting, being less active, body pains, diarrhoea, etc. 
(see figure 3). The mean duration of the fever as reported was about 5 days, (max 15 days and 
minimum of 1 day). At the time of the interview about 12% of those that had fever were still 
having the symptoms.  
 






















About 53.78% of those who had fever sought treatment within the first 24 hours. And about 
5.64% of people never sought any form of treatment (see Table 3 below). The main reason 
for not seeking treatment was that the fever was not serious enough to necessitate treatment. 
For those who sought treatment (see figure 4), the initial sources of treatment of febrile 
illness were: home or self treatment (36.07), drug stores (23.13%), government facilities 
(13.68%), private hospitals (22.39%) and traditional healer (4.73%). Self treatment with 
available medications at home was the most commonly reported source of treatment followed 
by purchase of drugs from drug stores without prescription. Only about 21.07% used a 
malaria diagnostic service to confirm the diagnosis of malaria before commencing treatment 




Table 10 Treatment seeking behaviour 
Variable Category number % of sample 
Have you or any members of your 
household had fever in the last 4 
weeks?  
Yes 413 24.70 
No 1259 75.30 
Total 1672 100 
Still suffering from fever? Yes 51 12.35 
No 362 87.65 
Total 413 100 
    
What was done immediately (within 
the first day of the fever)? 
Nothing, waited for 
fever to improve 
177 42.86 
Nothing, waited for 
symptoms to intensify 
18 4.36 
Sought treatment 
within the first day of 
onset of fever. 
218 53.78 
































    
Did you seek treatment later? Yes 184 94.36 
No 11 5.64 
Total 195 100 
    
Reason for not seeking treatment. Fever was not serious 9 72.73 
No money for treatment 2 27.27 
Total 11 100 
    
Where was treatment sought? Government 
clinic/hospital 
55 13.68 
Private clinic 90 22.39 
Drug store 93 23.13 







Total 402 100 
    
Was any antimalarial used for the 
treatment? 
Yes 336 81.36 
No 77 18.64 
Total 401 100 
Antimalarial drug used for 








Quinine 3 0.89 
ACT 22 6.55 
Don’t know 129 38.39 
Total 336 100 
 
Was any malaria blood test 
performed? 
Yes 83 21.07 
No 306 77.66 
Don’t know 5 1.27 
Total 394 100 
 
Result of malaria test Positive  56 67.47 
Negative 6 7.23 
Don’t know 21 25.30 
Total 83 100 
        

















Out of those who sought treatment, 83.79% used an antimalarial medication for the treatment 
of the fever. The various antimalarial drugs used were: sulphadoxine - pyrimethamine 
(31.25%), chloroquine (11.01%), artesunte monotherapy (8.93%), and quinine (0.89%).  Only 
a very small proportion (6.55%) of cases used an ACT for the treatment of fever. Over a third 
of the respondents (38.39%) did not know which antimalarial medication was used for the 
treatment.  
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For the respondents that know and have heard about ACTs, most agreed that they knew 
where to obtain ACTs and that they could afford to buy ACTs. Most of them also agreed that 
they preferred using ACTs and disagreed that ACTs had more side affects compared to other 
anti-malarial such as CQ and SP. 
Determinants of choice of treatment 
The results from the model of the treatment source and anti-malaria use are shown in tables 4 
and 5 respectively.  The factors that were significant in influencing treatment source are 
wealth index and level of education of the household head. Those from wealthier households 
were more likely to use private hospitals and informal sources treatment than use government 
facilities. Also, those wealthier households were more likely to seek care from a private 
facility than use informal sources of treatment compared to poorer households. The 
difference was however not significant. Individuals from a household where the household 
head had completed tertiary education were more likely to seek care from a private facility 
than seek care from informal sources compared to individuals from households were the 
household head had no education. Other factors such as marital status of the household head, 
sex, religion, occupation and household size were not found to influence the choice of the 
source of treatment. 






















              Variables                   Sources of treatment 
Government vs. informal 
sourcesb 
Private vs. informal 
sourcesb 
        β                                  P 
value 
β                      P value      
Wealth index       -.19                              
0.08* 
.08                       0.30 
Head 
Education 
Primary       -.08                               0.90 .47                       0.46 
Secondary         .41                              0.53 .62                       0.30 
Tertiary       -.04                               0.96 1.28                     0.06* 




Married       -.08                               0.90 .015                     0.98 
Not marriedb  
Sex of head 
 




Christian        .44                               0.17 .086                     0.76 
Muslimb   
Household size        .06                               0.53 .10                       0.92     
Age       -.02                               0.10 -.02                      0.47 
Employment 
status 
    
Formal sector         .73                               0.38 .68                       0.31 
Informal 
sector  
       .47                               0.61 .89                       0.21 
Unemployedb   
β: Regression coefficient;  *statistically significant 10% level;  bBase category 
 
The factors significantly influenced the type of antimalarial drug used were wealth index, 
level of education of the household head, occupation, household size and source of treatment. 
Individuals that are more likely to use ACTs compared to the artesunate monotherapy include 
those from wealthier homes, Individuals from households with educated heads (primary, 
secondary or tertiary), Individuals from households where the household head was employed 
People from larger households were more likely to use artesunate monotherapy than use ACT 
compared to individuals from smaller households. Also, individuals from larger households 
were more likely to use other medications (such as CQ & SP) than use an ACT compared to 
people from smaller households. This difference was however not significant.  
Those who sought care from government facilities were more likely to ACTs compared to 
than use monotherapies or other medications compared to those who sought care from private 
hospitals. Age, marital status, sex, religion of the household head was not found to influence 














Table 12: Multinomial logistic regression output: Determinants of choice of antimalarial 
(n=413) 
Variables                    Type of antimalarial used  
Artesunate monotherapy vs. 
ACTb  
Other antimalarial (CQ, 
SP & quinine) vs. ACTb   
   β                                        P value   β                       P value         
Wealth index -.33                                       0.09 -.10                     0.55 
Head 
Education 
Primary -18.23                                  0.001* -16.80                0.001* 
Secondary -17.61                                  0.001* -16.86                0.001* 
Tertiary -16.72                                  0.001* -16.33                 0.001* 




Married -.72                                       0.51 -.71                      0.45 
Not marriedb  
Sex of head 
 




Christian .52                                        0.42   -.17                       0.75 
Muslimb   
Household size .46                                        0.02* .22                        0.26 




    
Formal sector  -17.67                                 0.001* -17.88                 0.001 *   
Informal 
sector  






-2.79                                    0.006*      -2.09                    0.032* 







This study provides information on malaria treatment seeking behaviour and anti-malarial 
drugs use pattern in an endemic area in Lagos, Nigeria. The data were collected in December 
2009, more than 5 years after the change in treatment policy to ACT. Before this study little 
information exists on malaria treatment seeking and antimalarial drug use patterns at 
household level after the change in treatment policy. Most of the previous studies were 
conducted before the change in policy to ACT [14,15,17-19]. There is therefore limited 













Also the proportion that use ACTs within 24 hours of the onset of symptoms is not known 
[10].  
The study assessed the awareness of the current treatment policy and the antimalarial drug 
use patterns in the study population to determine the proportion that used an ACT for treating 
malaria.  The study also examined how socioeconomic and demographic factors affect the 
use various sources of treatment options and type of medication used for treating malaria in 
Mushin LGA, Lagos.  
The findings show that a very small proportion of the people with malaria within the recall 
period did not seek any form of treatment. This is similar to the finding of a previous study in 
Nigeria and other parts of Africa [20-22]. Of those who sought treatment, a great majority of 
them were treated at home with the use of various local brands of SP, CQ and artesunate 
monotherapy, which is similar to previous findings in Burkina Faso [23-25]. Self-treatment of 
uncomplicated malaria is common practice throughout Africa [13]. In line with previous 
studies from Nigeria and other countries in Africa, this study found that a great proportion of 
treatment for fever takes place at home and by the purchase of over the counter antimalarial 
medications from drugs stores/PMVs [13, 26, 27]. A drug sales outlet survey in Nigeria 
found that 16.7% of outlets stocked the recommended first-line treatment for uncomplicated 
malaria and that 92.5% of all outlets surveyed had non-artemisinin therapies (such as CQ and 
SP) in stock [28]. A significant proportion of drug store keepers and PMVs (more than 70%) 
did not know about the change in recommended malaria treatment from chloroquine and SP 
to ACTs [28]. Also, about 92% of the drug stores had SP in stock, 72% had CQ, whereas 
only 9% had ACTs [29]. There are also concerns that the drugs purchased from drug vendors 
could be fake and substandard [26].  
The findings also revealed very limited knowledge of the currently recommended first line 
medication for treating malaria. Only a tiny fraction of the respondents could correctly state 
the currently recommended first line medication i.e., ACT.  This result is similar to those 
from a qualitative survey conducted in Ona-Ara Local Government area (LGA), in south 
western Nigeria, where a limited number of the study participants had heard of the 
recommended ACT [30]. Despite the fact that ACTs are now the recommended first line 
medication for the treatment of uncomplicated malaria in Nigeria, less than 7% of the study 
sample reported the use of ACTs for treating malaria. The most common antimalarial used 
was SP, which is no longer recommended for treating malaria. Wealth index, level of 














The level of coverage of ACTs was found to be very low in the study population.  This 
suggests that the change in policy has not translated into a change in the choice of medication 
type by people suffering from malaria. The gap in knowledge on the current treatment policy 
could be responsible for most of the respondents still using ineffective medications.  A 
similar study in Cambodia in 2002, two years after the change in treatment policy to ACTs, 
found that only about 8% of people received the recommended treatment for malaria [31]. 
Prompt access to effective treatment is clearly associated with reduced malaria morbidity and 
mortality in endemic areas [32-34].   In April 2000 in Abuja, Nigeria, African heads of state 
made a commitment to ensure that at least 60% of those suffering from malaria have prompt 
access to affordable and appropriate treatment within 24 hours of onset of symptoms [32]. 
More recently, the Roll Back Malaria (RBM) partnership target aims that at least 80% of 
malaria patients are diagnosed and treated with effective anti-malarial treatments within 24 
hours of the onset of symptoms [9]. In this study, in about half of the instances, there was a 
delay in seeking treatment beyond one day after the onset of symptoms and a very small 
proportion of cases were confirmed by a laboratory diagnosis. Thus, efforts will be needed to 
educate this population on the currently recommended medications and the need for 'Early 
Diagnosis and Prompt Treatment (EDPT)’ in order to prevent complication of symptoms. 
Highly subsidized and quality-controlled ACT regimens are needed in order to improve 
access. Increasing access to ACTs and displacing artemisinin monotherapies from the market 
will help to delay resistance to artemisinin [35].  
The study has some limitations. One of the main limitations of this survey is that the sample 
size was relatively small and the sample may not be totally representative of the whole LGA. 
In addition, the reported findings from this study were based on self-reported information 
treatment seeking behaviour and drug use patterns. As in other similar studies, the data may 
be influenced by reporting bias due to incorrect recall of events or perceived pressure to 
provide “socially acceptable” answers. To assist in validating the responses, respondents’ 
were asked to show the package of the medication that was used if available. There was also 
a potential bias in excluding households in which an adult was not present on the day of the 
study.  In order to mitigate this, interviewers were asked the revisit the household on a second 
occasion.  
CONCLUSION 
Malaria remains a major cause of morbidity and mortality in many countries. The change in the recommended first line 
antimalarial from CQ and SP to ACTs, in most countries including Nigeria is a significant step towards reducing the burden 













not sufficient.  Steps needs to be taken to ensure that the policy is implemented and that effective medication for malaria 
treatment reach the people who need it. The findings of the survey have important implications for improving access to 
effective antimalarial drugs. The survey provided some information on the proportion of the people in the study area that use 
the recommended ACTs. There is need for greater efforts to increase awareness and use of the currently recommended 
antimalarial drugs. Health promotion and education interventions should stress promptness of use of effective antimalarial 
medications. Also, there has to be an increase in the public awareness programmes on the current malaria treatment policy in 
Nigeria. The programmes should provide comprehensive information on various aspects of malaria treatment and diagnosis, 
using various communication channels. There should also be efforts to improve access to appropriate drugs and rapid 
diagnostic test for malaria. An understanding of malaria treatment seeking behaviour of people suffering from malaria is 
very important for the control of malaria in endemic areas.  
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This policy brief is based on a study conducted in a suburb of Lagos, 
Nigeria on malaria treatment seeking behaviour and access to 
artemisinin combination therapy. We present some of the key 






Malaria is a major cause of morbidity and mortality, especially 
among children and pregnant women in Africa [1]. In Nigeria, 
malaria accounts for about 60% of outpatients' visits, 30% of 
childhood mortality, 25% of infant mortality and 11 per cent of 
maternal deaths and at least 300,000 children die of malaria annually 
[2]. Studies from various parts of Africa, including Nigeria have 
shown that the affordable and widely available anti-malarial – 
chloroquine – which was the major first line drug has lost its efficacy due to the emergence of 
chloroquine-resistant strains - Plasmodium falciparum. Artemisinin based combination 
therapies (ACTs) have been shown to be highly effective at treating Plasmodium falciparum 
in most places where they have been studied and are currently recommended in many 
countries (3). In line with the WHO recommendation, ACTs have been the first-line 
antimalarial in Nigerian since 2004. 
Who is this policy 
brief for? 
Policymakers, The Nigerian 
government, Nigeria Federal 
Ministry of Health, State 
ministries of health 
 
Key Messages 
Malaria is a major cause of 
morbidity and mortality in 
Nigeria. 
 
Prompt access to effective 
treatment is essential to 
reduce morbidity and 
mortality. 
 
ACTs are now currently the 
first-line drug for the 
treatment of malaria in 
Nigeria. 
 
There is limited level of 
awareness and usage of ACTs 
for the treatment of malaria 
in Nigeria. 
 
Health promotion and 
education interventions are 
needed to educate members 
of the public on the currently 
recommended antimalarial. 
 
Efforts are also needed to 
educate the public on the 
















Methods and Results 
 
A household survey was conducted in Mushin, Lagos to assess the malaria treatment seeking 
behaviour and determine the level of awareness and adherence to the current malaria 
treatment policy about 6 years after the change in policy in Nigeria. A key objective of the 
study was to assess level of awareness of ACTs and determine the proportion of people that 
used the recommended ACT in treating malaria. The survey involved interviewing 422 care 
givers or household heads in the study area. The following are highlights of some of the 
major findings and policy recommendations from the study.  
Delay in seeking treatment  
Our findings showed there was delay in seeking treatment beyond 24 hours of the onset of 
symptoms in more than 46% of cases. About 54% of those who had fever sought treatment 
within the first 24 hours. 
 
Home treatment was the most common source of treatment  
For those who sought treatment, the initial sources of treatment for febrile illness were: home 
or self treatment (35%), drug stores (25%), government facilities (22%), private hospitals 
(13%) and traditional healer (5%). See figure 1 below. 
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Most antimalarial were bought from PMVs  
Malaria medications were often purchased from sources such as drug stores and patent 
medicine vendors (PMVs) without any prescription. Many of these drug sellers are not 
regulated in Nigeria. A previous study found that significantly more than 70% of PMVs do 
not know about the current treatment for malaria [4].  
 
Low level of use of ACTs for treating malaria 
Despite the fact that ACT have been the recommended first line medication for the treatment 
of uncomplicated malaria in Nigeria for about 6 years now, less than 7% of the study sample 
reported the use of ACT for treating malaria (see figure 2 below). These findings confirm that 
there is still very low ACT coverage in some parts of Nigeria and suggests that the change in 
policy has not translated into a change in the choice of medication by people suffering from 
malaria.  Non-recommended drugs, such as CQ & SP were used in most of the cases.  
 
Figure 2: Antimalarial drug used for the treatment of fever 
 
Limited level of awareness about ACT 
Most of the respondents did not know the currently recommended first-line antimalarial. The 
findings revealed very limited knowledge of the currently recommended first line medication 
for treating malaria. Only about 3% mentioned that ACTs were now recommended for 
treating malaria. The gap in knowledge on the current treatment policy could be responsible 























Low level of use of laboratory diagnosis 




The level of coverage of ACTs was found to be very low in the study population. Six years 
since the adoption of this policy in Nigeria, our findings shows that a change policy alone is 
not sufficient. Steps needs to taken to ensure that the policy is implemented and that effective 
medications for malaria treatment reach the people who need it.  The gap in knowledge on 
the current treatment policy could be responsible for most of the respondents still using 
ineffective medications. 
Recommendations 
Increase Public Awareness of the ACT policy 
Information is an important condition for demand of goods and services. There is therefore, a 
need of regular health promotion and education interventions to educate members of the 
community on the current malaria treatment policy in Nigeria. The programmes should 
provide comprehensive information on various aspects of malaria treatment and diagnosis, 
using various communication channels. One way of doing this can be through radio and TV 
jingles promoting the use of ACTs. However, there should be innovative ways of 
communicating the message to people who do not have access to television, radio, or even 
electricity-especially those in rural areas. 
Public education of the need for Early Diagnosis and Prompt Treatment 
In about half of the instances, there was a delay in seeking treatment beyond 24 hours after 
the onset of symptoms and a very small proportion of cases were confirmed by a laboratory 
diagnosis.  Efforts are needed to educate the public on the need for 'Early Diagnosis and 
Prompt Treatment (EDPT)’ in order to prevent complication of symptoms. 
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